LaunchBio, Browne Consulting, and Silicon Valley Bank, a division of First Citizens Bank, are pleased to announce their next Investor Connect virtual event with Lilly Ventures.

They deploy customized engagement models to co-invest with world-class syndicate partners and offer counsel and connections within its global network with the goal of maximizing a company’s scientific impact.

Applications will be selected based on meeting the following criteria:

Geography:
Open to investments globally

Company type:
Seed, Series A stage investments in therapeutics companies within and outside the core areas of focus for Eli Lilly and Company

Areas of Interest:

• Biologics
• Cell therapies
• CRISPR-based therapies
• Gene therapies
• Protein-based therapies
• Regenerative Medicine
• RNA-based therapeutics
• Small molecules
• Vaccines

Therapeutic areas of interest include, but are not limited to:

• Open to all target organs/systems and a broad range of therapeutic areas, including cardiology, endocrinology, hematology, oncology, neurology, immunology, hematology and pulmonology

Stage:
Companies seeking funding for Seed, Series A